All Episodes

NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction

NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation

NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

NEJM Interview: Heather Hsu on an institutional conference series that provides opportunities for addressing the adverse effects of bias and medical racism.

The Marburg Virus Outbreak in Rwanda

NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.

NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.

NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.

NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.

NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.

NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.

NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.

NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.

NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors

NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer

NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

NEJM at ESMO — Ponsegromab in Cancer Cachexia

NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer

NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer

NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health.

NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy.

NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction

NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction

NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation

NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV

NEJM at ESC — PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation

NEJM at ESC — Transcatheter Repair versus Surgery for Secondary Mitral Regurgitation

NEJM at ESC — Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

NEJM at ESC — Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in Women

NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

NEJM at ESC — Beta Blocker Interruption or Continuation with Prior Myocardial Infarction

NEJM Interview: Revati Masilamani on a multitiered mentoring program aimed at supporting pathways to biomedical careers for students from diverse backgrounds.

NEJM Interview: Barron Lerner on challenges to physician expertise and restoring trust in the medical profession.

NEJM Interview: Gregg Gonsalves on the Covid pandemic’s lessons for addressing H5N1 influenza and other infectious threats.

NEJM Interview: Elizabeth Tobin-Tyler on the contribution of violence against women to unwanted pregnancies and to injury and death during the peripartum period.

NEJM Interview: Ida Sim on the translation of ethical principles into oversight of new forms of artificial intelligence.

NEJM Interview: Erin Fuse Brown on a vertical-consolidation trend that has given insurance companies increased control over the care-delivery system.

NEJM Interview: Evan Mullen on academic institutions’ participation in public debate, including in response to the opinions of their faculty members.

NEJM Interview: Nathaniel Chin on increases in the time and resources needed to diagnose and manage neurodegenerative diseases.

NEJM Interview: Christine Grady on the ethical challenges associated with recent developments in research on brain diseases.

NEJM Interview: Jessica Lewis on a group prenatal care program aimed at improving maternal and infant health in diverse patient populations.

NEJM Interview: Katharine Silbaugh on an approach to tobacco regulation that involves banning the sale of nicotine products to anyone born after a certain date.

Preparing for a Possible Avian Influenza Outbreak

Preparing for a Possible Avian Influenza Outbreak

NEJM Interview: Alicia Fernandez on the need for a focus on equity in patient experience and clinical outcomes in the health care sector.

NEJM Interview: Joshua Sharfstein on a shift by the Supreme Court that is limiting the ability of states, Congress, and federal agencies to protect public health.

NEJM Interview: Kevin Schulman on unionization as a response to consolidation and corporatization in health care.

NEJM Interview: Stephanie Fullerton on the rise of clinical genetic testing and related ethical considerations.

NEJM Interview: R. Alta Charo on the potential implications of the Alabama Supreme Court’s decision in LePage v. Center for Reproductive Medicine.

NEJM Interview: Daniel Sulmasy on the role of spirituality in patient care.

NEJM Interview: Dhruv Khullar on the trend of hospital acquisition of physician practices in the United States.

NEJM Interview: José Rodríguez on an intervention aimed at recruiting a diverse class into a family medicine residency program.

NEJM Interview: Ilya Golovaty on platforms offering direct-to-consumer prescribing of medications for weight management.

NEJM Interview: Dave Chokshi on ethical issues faced by safety-net health systems in the United States.

NEJM Interview: David Higgins on public confidence in the value of childhood vaccines and the importance of combating misinformation about vaccination.

NEJM Interview: Andrew Lea on how experience with a 1970s computerized diagnostic program can inform efforts to implement machine-learning prediction models in medicine.

NEJM Interview: Thomas Gallagher on historical and current ethical approaches to responding to harmful medical errors.

NEJM Interview: Joseph Friedman on increases in drug-related mortality among adolescents and approaches to overdose prevention.

NEJM Interview: Crystal Cené on the potential benefits, particularly for Black birthing people, of partnerships between perinatal care providers and community-based doulas.

NEJM Interview: Bernard Lo on the evolution of the ethical and legal framework for making medical decisions for patients who lack decision-making capacity.

NEJM Interview: Laura Stark on the history of rules governing human-subjects research and potential lessons for the regulation of artificial intelligence.

Is Xenotransplantation Ready for Prime Time? — ITT Episode 22

NEJM Interview: Robert Yeh on delays between FDA authorization and Medicare coverage of new medical devices and proposed reforms to current systems.

NEJM Interview: Hao Yu on a new Tennessee law that expands practice opportunities for some international medical graduates.

NEJM Interview: Nelson Wandera on an outbreak of Rift Valley fever virus in Uganda and an approach aimed at advancing surveillance, treatment, and research.

NEJM Interview: Mason Marks on draft guidance on psychedelics research.

NEJM Interview: David Grabowski on a proposed federal rule mandating a specific minimum-staffing standard for U.S. nursing homes.

NEJM Interview: Kekoa Taparra on the Lāhainā fires and persistent threats to community recovery.

NEJM Interview: Peter Hotez on concerns that yellow fever could return to the southern United States.

NEJM Interview: Joelle Abi-Rached on the social, political, economic, and ethical factors that go into a decision to declare that a public health crisis is over.

NEJM Interview: Rosemary Sokas on the risk of heat-related illness among U.S. workers as temperatures increase.

NEJM Interview: Atheendar Venkataramani on affirmative action and how hope and opportunity can affect health and well-being.

NEJM Interview: Steven Woloshin on an updated U.S. Preventive Services Task Force recommendation regarding the starting age for mammography screening.

NEJM Interview: Erin Fuse Brown on the role of corporate-practice-of-medicine laws in a changing health care environment.

NEJM Interview: Salim Abdool Karim on a National Institutes of Health policy that will add new requirements for foreign subrecipients of funding.

NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.

NEJM Interview: Valerie Montgomery Rice on opportunities for achieving a diverse student body and workforce after the Supreme Court’s decision on affirmative action.

NEJM Interview: Catherine Godfrey on addressing mental health programming gaps for people living with HIV in Africa.

NEJM Interview: Douglas Krakower on the potential benefits associated with making preexposure prophylaxis for HIV available without a prescription.

NEJM Interview: Adam Rodman on the potential effects of generative artificial intelligence on medical education and clinical practice.

NEJM Interview: David Blumenthal on opportunities to establish a national public health reporting system.

NEJM Interview: Ge Bai on whether nonprofit hospitals provide enough community benefit to justify favored tax status.

NEJM Interview: David Hunter on factors that have led to breakdowns in care in the United Kingdom’s National Health Service.

NEJM Interview: Jean Nachega on PEPFAR’s achievements and remaining challenges in HIV prevention and treatment in sub-Saharan Africa.

NEJM Interview: Sam Halabi on facilitating sharing and aggregation of pathogen genomic sequence data for public health objectives.

NEJM Interview: Lawrence Gostin on political and scientific controversy about the emergence of SARS-CoV-2.

Dr. Fauci on Infectious Disease Challenges

NEJM Interview: Richard Mizelle on how long-standing issues related to structural racism culminated in a state of emergency in Mississippi in 2022.

NEJM Interview: Clifford Rosen on gaps in the understanding of long Covid and in access to high-quality care for patients.

NEJM Interview: William Riley on approaches to addressing current and projected platelet shortages in the United States.

The Lasting Effects of Covid-19